Overview of Investor Relations Capabilities. Rx COMMUNICATIONS. Specialists in the life science and healthcare industries Partner-driven -- Senior level counsel on EVERY account Partners have been through up and down market cycles, various political healthcare agendas and technology trends.
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Services for Private Companies
Services for Public Companies
Melody A. Carey, Co-President
The Multicare Companies, Inc.
Rhonda Chiger, Co-President
Eric Goldman, Vice President
Paula B. Schwartz, Senior Vice President
Helped to grow Alexion Pharmaceuticals’ institutional shareholder base from 30% in 1996 to approximately 95% today.
Launched not-for-profit Immune Tolerance Institute resulting in broad coverage in the U.S. including CBS Radio Network, San Francisco Business Times and Drug Discovery News
Garnered coverage for Catalyst Pharmaceutical Partners’ compound for cocaine addiction. Placements included cover stories in Newsweek, Scientific American Mind and NeuroInvestment
Designed and implemented IR program for American CareSource Holdings which led the company to be ranked as the number one stock performer on The NASDAQ Capital Market for 2008.
An aggressive investor outreach campaign on behalf of Genaissance Pharmaceuticals allowed Genaissance to regain compliance with Nasdaq’s $1 listing rule requirement.
Guided Kos Pharmaceuticals through a failed marketing alliance which caused over two million shares to trade (four times the average daily trading volume) and the stock never dropped below 2%.
Arranged feature coverage focused on Hodgkins and non-Hodgkins lymphoma for MethylGene with Genetic Engineering News, Pink Sheet, BioCentury and Pharmawire
Guided ABIOMED on issues management surrounding FDA panel meeting. Put FDA’s request for additional data into perspective with reporters and investors. CNBC interview key part of strategy.
Implemented aggressive IR program for PharmAthene, Inc. which enabled the company to obtain coverage from two new sell-side analysts, garner investments from four new institutional funds and increase trading volume by three-fold within nine months.
Rx Communications was named
Best Small PR Agency
byLeague of American Communications Professionals
We are pleased to announce that Rx
Communications has been selected by PR Week
as a finalist for
Boutique PR Agency of the Year
Rx Communications Group was honored with the 2008
Stevie Award for Best Investor Relations Program
for work on behalf of specialty
pharmaceutical company, NexMed, Inc.
We are also pleased to share that our work for
ImpactRx has won an Honorable Mention
Award in LACP’s (League of American
Communications Professionals) 2002 Publicity
Rx Communications was honored with the 2002 SABRE
Awards Certificate of Excellence for Building a North
American Investor Base for client Syngenta AG.
Rx Communications received an honorable Mention
Award from PR News, as part of the PR News Platinum PR
Awards 2003. The award was issued in the
Financial/Investor Relations category, for the company's
work on behalf of Genaissance Pharmaceuticals, Inc.
Rx Communications Group, LLC
445 Park Avenue
New York, NY 10022